Karin A. Hughes

EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA.

Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA.

Crosspoint Venture Partners (Crosspoint Venture Partners) is a venture capital firm founded in 1970 by John B. Mumford. The firm is headquartered in Redwood City, California.

Synecor LLC (Synecor) is a venture capital firm founded in 2000 by Richard S. Stack, William N. Starling, and Judith L. Swain. The firm is headquartered in Chapel Hill, North Carolina.

GenoRx, Inc. develops DNA on a chip technology. It develops bioelectronic detection tools that will provide the creation of targeted therapeutics, improved diagnostics and healthier agricultural products. It also provides Biosensing chips to rapidly characterize RNA and DNA for disease diagnosis and scientific research. The company was founded in 2000 and is headquartered in Hayward, CA.

Novasys Medical, Inc. develops therapies for women's health. The company was founded by Stuart D. Edwards and Peter S. Edelstein on June 24, 1999 and is headquartered in Newark, CA.

GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ.

Cartilix, Inc. develops surgical devices and associated biomaterials to treat focal cartilage defects in joints. Its technology is used in wound sealing solutions, spinal disc regeneration, and other biological interfaces. The company was founded by Frank Huerta, Norman A. Marcus, and Jennifer Elisseeff in July 2004 and is headquartered in Foster City, CA

Respiratory Motion, Inc. develops medical devices. The firm specializes in clinical research, clinical evaluation and testing. Its product ExSpiron 1Xi, measures minute ventilation non-invasively. The company was founded by Jenny E. Freeman, Alexander Panasyuk and Svetlana Panasyuk in March 2010 and is headquartered in Waltham, MA.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Matrix Management Corp. (Matrix Partners) is a venture capital firm founded in 1977 by Paul Ferri. The firm is headquartered in Cambridge, Massachusetts with additional offices in China and India.

De Novo Ventures LLC (De Novo ventures) is a venture capital firm founded in 2000 by Frederick Dotzler, Richard Ferrari and David Mauney. The firm is headquartered in Menlo Park, California.

Cortek, Inc. develops and markets spinal products. Its products are used in the treatment of chronic back pain. It currently markets allografts and proprietary instrument systems for anterior lumbar interbody fusion (ALIF), posterior lumbar interbody fusion (PLIF) and cervical fusion procedures. The company is headquartered in Dedham, MA.

SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ.

Delphi Ventures Inc (Delphi Ventures) is a venture capital firm founded in 1988 by James Bochnowski. The firm is headquartered in San Mateo, California.

Part of Deutsche Bank AG, Deutsche Bank Corp. is a company based in New York, NY.

Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA.

DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA.

Neuron23, Inc. is a clinical-stage biotechnology company based in an undisclosed location. The American company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The company was founded by Adam Knight and Nancy E. Stagliano has been the CEO of the company since 2019.

True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA.

Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.